CHRONIC GVHD
Clinical trials for CHRONIC GVHD explained in plain language.
Never miss a new study
Get alerted when new CHRONIC GVHD trials appear
Sign up with your email to follow new studies for CHRONIC GVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Study withdrawn: drug access for Post-Transplant blood issues never started
Disease control TerminatedThis study was designed to give people who responded well to fostamatinib in an earlier trial continued access to the drug for up to 21 months. The goal was to keep blood cell levels stable after a stem cell transplant. However, the study was withdrawn before enrolling any partic…
Matched conditions: CHRONIC GVHD
Phase: PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Immune cell combo shows promise for tough transplant complication
Disease control OngoingThis early-stage trial tests a combination of donor immune cells (Tregs) and a low-dose protein (IL-2) to control chronic graft-versus-host disease (cGVHD), a condition where donor cells attack the recipient's body after a stem cell transplant. The study includes 25 people whose …
Matched conditions: CHRONIC GVHD
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Can video calls ease chronic GVHD? small study tests Tele-Palliative care
Symptom relief OngoingThis study looks at whether a palliative care program delivered via video calls is practical and well-received by people with moderate to severe chronic graft-versus-host disease (cGVHD), a complication after a stem cell transplant. Ten adults will participate in up to three tele…
Matched conditions: CHRONIC GVHD
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 17, 2026 02:53 UTC
-
Scientists probe skin cells to unravel GVHD mystery
Knowledge-focused OngoingThis study looks at how different types of immune cells (dendritic cells) in the skin are involved in graft-versus-host disease (GVHD) after a bone marrow transplant. Researchers will collect skin samples and blood from 22 adults with acute or chronic skin GVHD to analyze cell ty…
Matched conditions: CHRONIC GVHD
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 17, 2026 02:57 UTC